Influence	influence	O	O
of	of	O	O
diet	diet	O	O
free	free	O	O
of	of	O	O
NAD-precursors	nad-precursors	O	O
on	on	O	O
acetaminophen	acetaminophen	S_chemical	O
hepatotoxicity	hepatotoxicity	O	S_disease
in	in	O	O
mice	mice	O	O
.	.	O	O

Recently	recently	O	O
,	,	O	O
we	we	O	O
demonstrated	demonstrated	O	O
the	the	O	O
hepatoprotective	hepatoprotective	O	S_disease
effects	effects	O	O
of	of	O	O
nicotinic	nicotinic	B_chemical	O
acid	acid	I_chemical	O
amide	amide	I_chemical	O
,	,	O	O
a	a	O	O
selective	selective	O	O
inhibitor	inhibitor	O	O
of	of	O	O
poly(ADP-ribose	poly(adp-ribose	O	O
)	)	O	O
polymerase	polymerase	O	O
(	(	O	O
PARP	parp	S_chemical	O
;	;	O	O
EC	ec	O	O
2.4.2.30	2.4.2.30	O	O
)	)	O	O
on	on	O	O
mice	mice	O	O
suffering	suffering	O	O
from	from	O	O
acetaminophen	acetaminophen	S_chemical	O
(AAP)-hepatitis	(aap)-hepatitis	O	O
,	,	O	O
suggesting	suggesting	O	O
that	that	O	O
the	the	O	O
AAP-induced	aap-induced	O	O
liver	liver	O	B_disease
injury	injury	O	I_disease
involves	involves	O	O
a	a	O	O
step	step	O	O
which	which	O	O
depends	depends	O	O
on	on	O	O
adenoribosylation	adenoribosylation	O	O
.	.	O	O

The	the	O	O
present	present	O	O
study	study	O	O
investigates	investigates	O	O
the	the	O	O
effects	effects	O	O
of	of	O	O
a	a	O	O
diet	diet	O	O
free	free	O	O
of	of	O	O
precursors	precursors	O	O
of	of	O	O
NAD	nad	O	O
,	,	O	O
the	the	O	O
substrate	substrate	O	O
on	on	O	O
which	which	O	O
PARP	parp	S_chemical	O
acts	acts	O	O
,	,	O	O
in	in	O	O
female	female	O	O
NMRI	nmri	O	O
mice	mice	O	O
with	with	O	O
AAP	aap	S_chemical	O
hepatitis	hepatitis	O	S_disease
and	and	O	O
evaluates	evaluates	O	O
the	the	O	O
influence	influence	O	O
of	of	O	O
simultaneous	simultaneous	O	O
ethanol	ethanol	S_chemical	O
consumption	consumption	O	O
in	in	O	O
these	these	O	O
animals	animals	O	O
.	.	O	O

Liver	liver	O	B_disease
injuries	injuries	O	I_disease
were	were	O	O
quantified	quantified	O	O
as	as	O	O
serum	serum	O	O
activities	activities	O	O
of	of	O	O
glutamate-oxaloacetate	glutamate-oxaloacetate	O	O
transaminase	transaminase	O	O
(	(	O	O
GOT	got	O	O
)	)	O	O
and	and	O	O
glutamate-pyruvate	glutamate-pyruvate	O	O
transaminase	transaminase	O	O
(	(	O	O
GPT	gpt	O	O
)	)	O	O
.	.	O	O

While	while	O	O
AAP	aap	S_chemical	O
caused	caused	O	O
a	a	O	O
117-fold	117-fold	O	O
elevation	elevation	O	O
of	of	O	O
serum	serum	O	O
transaminase	transaminase	O	O
activities	activities	O	O
in	in	O	O
mice	mice	O	O
kept	kept	O	O
on	on	O	O
a	a	O	O
standard	standard	O	O
laboratory	laboratory	O	O
diet	diet	O	O
,	,	O	O
which	which	O	O
was	was	O	O
significantly	significantly	O	O
exacerbated	exacerbated	O	O
by	by	O	O
ethanol	ethanol	S_chemical	O
and	and	O	O
inhibited	inhibited	O	O
by	by	O	O
nicotinic	nicotinic	B_chemical	O
acid	acid	I_chemical	O
amide	amide	I_chemical	O
(	(	O	O
NAA	naa	O	O
)	)	O	O
,	,	O	O
adverse	adverse	O	B_disease
effects	effects	O	I_disease
were	were	O	O
noted	noted	O	O
in	in	O	O
animals	animals	O	O
fed	fed	O	O
a	a	O	O
diet	diet	O	O
free	free	O	O
of	of	O	O
precursors	precursors	O	O
of	of	O	O
NAD	nad	O	O
.	.	O	O

In	in	O	O
these	these	O	O
animals	animals	O	O
,	,	O	O
only	only	O	O
minor	minor	O	O
increases	increases	O	O
of	of	O	O
serum	serum	O	O
transaminase	transaminase	O	O
activities	activities	O	O
were	were	O	O
measured	measured	O	O
in	in	O	O
the	the	O	O
presence	presence	O	O
of	of	O	O
AAP	aap	S_chemical	O
,	,	O	O
and	and	O	O
unlike	unlike	O	O
the	the	O	O
exacerbation	exacerbation	O	O
caused	caused	O	O
by	by	O	O
ethanol	ethanol	S_chemical	O
in	in	O	O
mice	mice	O	O
on	on	O	O
a	a	O	O
standard	standard	O	O
diet	diet	O	O
,	,	O	O
the	the	O	O
liver	liver	O	B_disease
damage	damage	O	I_disease
was	was	O	O
inhibited	inhibited	O	O
by	by	O	O
50	50	O	O
%	%	O	O
by	by	O	O
ethanol	ethanol	S_chemical	O
.	.	O	O

A	a	O	O
further	further	O	O
64	64	O	O
%	%	O	O
reduction	reduction	O	O
of	of	O	O
hepatitis	hepatitis	O	S_disease
was	was	O	O
observed	observed	O	O
,	,	O	O
when	when	O	O
NAA	naa	O	O
was	was	O	O
given	given	O	O
to	to	O	O
ethanol/AAP-mice	ethanol/aap-mice	O	O
.	.	O	O

Our	our	O	O
results	results	O	O
provide	provide	O	O
evidence	evidence	O	O
that	that	O	O
the	the	O	O
AAP-induced	aap-induced	O	O
hepatitis	hepatitis	O	S_disease
and	and	O	O
its	its	O	O
exacerbation	exacerbation	O	O
by	by	O	O
ethanol	ethanol	S_chemical	O
can	can	O	O
either	either	O	O
be	be	O	O
reduced	reduced	O	O
by	by	O	O
end-product	end-product	O	O
inhibition	inhibition	O	O
of	of	O	O
PARP	parp	S_chemical	O
by	by	O	O
NAA	naa	O	O
or	or	O	O
by	by	O	O
dietary	dietary	O	O
depletion	depletion	O	O
of	of	O	O
the	the	O	O
enzyme	enzyme	O	O
's	's	O	O
substrate	substrate	O	O
NAD	nad	O	O
.	.	O	O

We	we	O	O
see	see	O	O
the	the	O	O
main	main	O	O
application	application	O	O
of	of	O	O
NAA	naa	O	O
as	as	O	O
for	for	O	O
the	the	O	O
combinational	combinational	O	O
use	use	O	O
in	in	O	O
pharmaceutical	pharmaceutical	B_chemical	O
preparations	preparations	I_chemical	O
of	of	O	O
acetaminophen	acetaminophen	S_chemical	O
in	in	O	O
order	order	O	O
to	to	O	O
avoid	avoid	O	O
hepatic	hepatic	O	B_disease
damage	damage	O	I_disease
in	in	O	O
patients	patients	O	O
treated	treated	O	O
with	with	O	O
this	this	O	O
widely	widely	O	O
used	used	O	O
analgesic	analgesic	O	O
.	.	O	O

